Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-038510

EVP, Research & CSO sold 3,510 shares at an average $38.00 ($133,384)

  • EVP, Research & CSO acquired 3,510 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-06-19 Option exercise +3,510 $1.53 $5,370 3,510 D
Virgin Herbert EVP, Research & CSO 2020-06-19 Sale −1,755 $38.00 $66,694 1,755 D
Virgin Herbert EVP, Research & CSO 2020-06-19 Sale −1,755 $38.00 $66,690 0 D
Derivatives
Virgin Herbert EVP, Research & CSO 2020-06-19 Option exercise · Stock Option (Right to Buy) −3,510 538,875 D
Open-market sales · 3,510 sh · avg $38.00 · $133,384
Loading xslF345X03/doc4.xml…